Short description
Ordaos creates bespoke mini-proteins to help drug hunters deliver life-saving treatments.
Description
Ordaōs is a human-enabled, machine-driven drug design company. We create customized mini-proteins that help pharma and biotechs around the world deliver safer and more effective life-saving treatments in a fraction of the time of traditional discovery methods. miniPRO proteins are created and evaluated in silico, and then rigorously tested in vitro, which enables us to reliably and repeatedly deliver de novo solutions that meet our client’s stringent requirements at scale, including novelty and probability of clinical success. At Ordaōs, we help birth novel therapies that reduce patient suffering, improve health, and extend life.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Manhattan, New York, United States, North America
Founded on
December 23, 2019
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noway Youcantaccess, Uh Ohhhh, Noaccess, Noaccess, Noaccessforu, Noaccessforu, Blurry Noaccess
Sign in for full access
Founders
David Longo, Ulo Palm, Ziwei Liang